Important key points about revised Schedule-M 2024

Revised Schedule M 2023

What are the key features of Revised Schedule M for manufacturing companies? Ministry of Health and Family Welfare, Government of India, issued a notification regarding the implementation of revised Schedule-M 2024 by all pharmaceutical formulation companies in India.  The initial…

Gastroesophageal reflux disease (GERD)

Revised Schedule M 2023

GERD: Decoding the Fire Within Gastroesophageal Reflux Disease (GERD) is a medical condition when the undigested content in the stomach moves up into the esophagus. This condition creates a sensation in the chest that is also known as heartburn. It is…

What are Nonsteroidal Anti-Inflammatory Drugs?

Definition of Nonsteroidal Anti-Inflammatory Drugs Nonsteroidal anti-inflammatory drugs (NSAIDs) are a class of medicines that are used in severe to moderate pain situations. These medicines reduce inflammation, pain, and fever. The mechanism of action of these drugs is to block…

DPCO List for 29 Formulations October 2023

 NPPA issued a list of 29 Formulations in October 2023 National Pharmaceutical Pricing Authority (NPPA) passed an Order S.O. 4660(E) (E) on 25th October 2023. In this order, NPPA revised the ceiling price of 29 formulations at the request of several…

SOP for Calibration of Dissolution test appratus

Revised Schedule M 2023

Principle of Dissolution Test Apparatus Dissolution is the analysis process in which the analyzed substance forms a solution. In this testing measurement of the content and rate of dissolving in the solution from a dosage form, such as a tablet,…